Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.

Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.
复制标题

通过将硬脂酰抗菌肽 CAMEL 与 P 物质结合来改善 NK1R 靶向基因递送。

DOI:
10.1016/j.bmcl.2020.127353
复制
发表时间:
2020-08
影响因子:
2.7
通讯作者:
Zhang Wei
Zhang Wei
中科院分区:
医学4区
文献类型:
--
作者:
Song Jingjing;Huang Sujie;Ma Panpan;Zhang Bao;Jia Bo;Zhang Wei

文献摘要

参考文献

相似文献

特异性是阻碍非病毒载体应用于癌症基因治疗的关键条件。在之前的研究中,我们利用抗菌肽 CAMEL 的 N 末端硬脂基化,开发了一种高效的基因载体硬脂基-CAMEL。 P 物质 (SP) 是一种 11 个残基的神经肽,与在许多癌细胞系中表达的神经激肽-1 受体 (NK1R) 结合后迅速进入细胞。本研究通过将SP与硬脂基-CAMEL的C端缀合,构建了NK1R靶向基因载体硬脂基-CMSP。我们的结果表明,与硬脂基-CAMEL 相比,硬脂基-CMSP 对表达 NK1R 的细胞表现出显着的转染特异性。因此,硬脂酰-CMSP/p53质粒复合物对HEK293-NK1R细胞的抗增殖活性明显高于对HEK293细胞的抗增殖活性,而硬脂酰-CAMEL/p53质粒复合物在抗增殖活性中没有表现出这种特异性。因此,NK1R靶向配体SP的缀合是构建有效的癌症靶向非病毒基因载体的简单而成功的策略。
Specificity is a crucial condition that hampers the application of non-viral vectors for cancer gene therapy. In a previous study, we developed an efficient gene vector, stearyl-CAMEL, usingN-terminal stearylation of the antimicrobial peptide CAMEL. Substance P (SP), an 11-residue neuropeptide, rapidly enters cells after binding to the neurokinin-1 receptor (NK1R), which is expressed in many cancer cell lines. In this study, the NK1R-targeted gene vector stearyl-CMSP was constructed by conjugating SP to the C-terminus of stearyl-CAMEL. Our results indicated that stearyl-CMSP displayed significant transfection specificity for NK1R-expressing cells compared with that shown by stearyl-CAMEL. Accordingly, the stearyl-CMSP/p53 plasmid complexes had significantly higher antiproliferative activity against HEK293-NK1R cells than they did against HEK293 cells, while the stearyl-CAMEL/p53 plasmid complexes did not show this specificity in antiproliferative activity. Consequently, conjugation of the NK1R-targeted ligand SP is a simple and successful strategy to construct efficient cancer-targeted non-viral gene vectors.
DOI: 10.1016/j.jconrel.2013.08.300
发表时间: 2013-12-28
期刊: Journal of controlled release : official journal of the Controlled Release Society
影响因子: --
作者:
Kullberg M;McCarthy R;Anchordoquy TJ
通讯作者: Anchordoquy TJ
DOI: 10.1038/mt.2013.32
发表时间: 2013-05-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Senzer, Neil;Nemunaitis, John;Chang, Esther H.
通讯作者: Chang, Esther H.
DOI: 10.1016/j.coph.2019.01.003
发表时间: 2019-08-01
影响因子: 4
作者:
Klimpel, Annika;Luetzenburg, Tamara;Neundorf, Ines
通讯作者: Neundorf, Ines
DOI: 10.1007/s00249-011-0682-7
发表时间: 2011-04-01
影响因子: 2
作者:
Splith, Katrin;Neundorf, Ines
通讯作者: Neundorf, Ines
DOI: 10.1016/j.addr.2015.02.008
发表时间: 2015-06-29
影响因子: 16.1
作者:
Boisguérin P;Deshayes S;Gait MJ;O'Donovan L;Godfrey C;Betts CA;Wood MJ;Lebleu B
通讯作者: Lebleu B